www.fdanews.com/articles/176262-fda-greenlights-nevro-leads
FDA Greenlights Nevro Leads
April 18, 2016
The FDA has approved Nevro’s new surgical leads, which are intended for use with Senza Spinal Cord Stimulation, a neuromodulation platform delivering HF10 therapy.
The SCS therapy system delivers electrical pulses via a compact battery-powered generator implanted under the skin located near the spinal cord to treat chronic leg and back pain. — Joya Patel